← All diseases Infectious diseases

Chronic hepatitis B

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (82)Meta-analysis (26)Treatment guideline (6)Randomized trial (32)Systematic review (10)Phase 3 study (8)Clinical trial (630)Review article (169)Early study (phase 1 or 2) (25)Case reports (96)Laboratory or animal research (16)Commentary or Editorial (50)Retracted publication (2) Studies currently recruiting participants only (31)

Filter

Publications and studies (2004)

• Perilipin2 inhibits the replication of hepatitis B virus deoxyribonucleic acid by regulating autophagy under high-fat conditions. (2023/12/25) ♡
• The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease. (2023/12/22) ♡
• Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B. (2023/12/21) ♡
• Effect of multidisciplinary team care on patient survival in chronic hepatitis B or C hepatocellular carcinoma. (2023/12/21) ♡
• [Analysis of the therapeutic efficacy and factors influencing sequential combination of nucleos (t) ide analogues with pegylated interferon alpha for 48~96 weeks in the treatment of patients with chronic hepatitis B]. (2023/12/20) ♡
• [A study of the clinical curative effect of nucleos (t) ide analogues treated to pegylated interferon-α add-on therapy in patients with chronic hepatitis B]. (2023/12/20) ♡
• Prevalence of hepatitis D virus infection among patients with chronic hepatitis B infection at a tertiary care center in Thailand. (2023/12/19) ♡
• Liver iron overload and fat content analyzed by magnetic resonance contribute to evaluating the progression of chronic hepatitis B. (2023/12/19) ♡
• Steady Decline of HBV DNA Load under NAs in Lymphoma Patients and a Higher Level of Anti-HBC Predict HBV Reactivation. (2023/12/19) ♡
• Treatment cessation in HBeAg-negative chronic hepatitis B: clinical response is associated with increase in specific proinflammatory cytokines. (2023/12/18) ♡
• The effect of FOXP3 genetic polymorphisms on correlations with hepatitis B virus-hepatocellular carcinoma: A case-control study. (2023/12/12) ♡
• The importance of triple panel testing for hepatitis B and the burden of isolated anti-hepatitis B core antibodies within a community sample. (2023/12/11) ♡
• EALT-f: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population - China, 2010-2023. (2023/12/08) ♡
• Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B and Antigen-Negative Patients. (2023/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. (2023/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis B Virus and MicroRNAs: A Bioinformatics Approach. (2023/12/07) ♡
• IL-15 boosts activated HBV core-specific CD8 (+) progenitor cells via metabolic rebalancing in persistent HBV infection. (2023/12/07) ♡
• Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir. (2023/12/06) ♡
• Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma. (2023/12/05) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms. (2023/12/05) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Disseminated Miliary and Intestinal Tuberculosis Mimicking Inflammatory Bowel Disease. (2023/12/05) ♡
• Comparative analysis of monocyte-derived dendritic cell phenotype and T cell stimulatory function in patients with acute-on-chronic liver failure with different clinical parameters. (2023/12/04) ♡
• Efficacy of pegylated interferon α-2b plus entecavir therapy and predictors of treatment success in children with chronic hepatitis B. (2023/12/04) ♡
• Where does that data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya. (2023/12/02) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels. (2023/12/01) ♡
• First 15 Years of Assisted Reproductive Technology Using Washed Sperm in HIV-Positive Individuals Under Antiretroviral Therapy: Sweden's Nationwide Outcomes. (2023/12/01) ♡
• Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgenic and miR-122. (2023/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B? (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic applications of thymosin peptides: a patent landscape 2018-present. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Telbivudine-induced rhabdomyolysis in a patient undergoing haemodialysis: A case report and review of literature. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Role of hepatitis B virus and protein and core protein in hepatocarcinogenesis] (2023/12/01) ♡
• Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients-A Cohort from the North-Eastern Part of Romania. (2023/11/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Regulation of Mitochondrial Metabolism by Hepatitis B Virus. (2023/11/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators. (2023/11/30) ♡
• Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection. (2023/11/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immune modulation of gut microbiota and its metabolites in chronic hepatitis B. (2023/11/29) ♡
• Core Promoter and Pre-Core Variants of the Hepatitis B Virus (HBV) Are Frequent in Chronic Hepatitis B HBeAg-Negative Patients Infected by Genotypes A and D. (2023/11/29) ♡
• Risk of dementia in the elderly with non-alcoholic fatty liver disease: A nested case-control study in the Republic of Korea. (2023/11/29) ♡
• Tenofovir amibufenamide vs tenofovir alafenamide for treating chronic hepatitis B: A real-world study. (2023/11/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma. (2023/11/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA. (2023/11/25) ♡
• Patient acceptability of, and attitudes towards, hepatitis B cure research — A scoping review and identification of knowledge gaps. (2023/11/24) ♡
• [Study of the predictive role of serum HBV RNA on HBeAg serological conversion in children with chronic hepatitis B]. (2023/11/20) ♡
• [Limitations and cautions of a family history of HBV-related cirrhosis/hepatocellular carcinoma as a condition for initiating antiviral therapy in patients with HBV infection]. (2023/11/20) ♡
• Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK. (2023/11/15) ♡
• Perspectives on Outcome Prediction in Patients With Chronic Hepatitis B Virus Infection. (2023/11/14) ♡
• Hepatitis B e Antigen-Negative Single Hepatocyte Analysis Shows Transcriptional Silencing and Slow Decay of Infected Cells With Treatment. (2023/11/02) ♡
• Evaluation of the Curative Effect of Treating HBV-related Liver Fibrosis/Cirrhosis Based on the Method of Removing Turbidity and Regulating the Liver. (2023/11/01) ♡
• Use of HBV RNA and to predict change in serological status and disease activity in CHB. (2023/11/01) ♡
• Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference. (2023/11/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.